Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
05/18/1994 | CN1086812A Process for preparing novel aromatase inhibiting 4(5)-imidazoles |
05/18/1994 | CN1024545C Preparation for 4-demethoxy-4-amino-zhendinmycin-one |
05/17/1994 | US5312833 Method of inhibiting tumor growth using xanthocillin X dimethylether |
05/17/1994 | US5312831 Immunology, anticarcinogenic agents and AIDS treatment |
05/17/1994 | US5312815 Fungicidal (+)-2-(2,4-difluorophenyl)-3-methyl-1-(1H-1,2,4-triazol-1-yl)3-(6-(1H-1,2,4-triazol-1-yl)pyridazin-3-ylthio) butan-2-ol |
05/17/1994 | US5312814 α-phosphonocarboxylate squalene synthetase inhibitors |
05/17/1994 | US5312736 DNA-sequence encoding the analog; expression vector containing the sequence; transformed or transfected microorganism or cell line comprising the vector; culture preparation of analog; drug including analog |
05/17/1994 | US5312629 Method for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases |
05/17/1994 | CA1329616C Aromatase inhibiting 4(5)-imidazoles |
05/17/1994 | CA1329609C Araliphatylaminoalkanediphosphonic acids |
05/17/1994 | CA1329604C Pharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles contained therein, and processes for the preparation of these heterocyclic compounds |
05/17/1994 | CA1329541C Pharmaceutical composition for relieving side effects of platinum-containing drugs |
05/13/1994 | CA2102848A1 Altered affinity polypeptides of metal chelate binding antibodies |
05/11/1994 | WO1994010331A1 Angiogenesis inhibitory antibodies |
05/11/1994 | WO1994010309A1 Novel p-selectin ligand protein |
05/11/1994 | WO1994010307A1 Transcription factor dp-1 |
05/11/1994 | WO1994010202A1 Vascular endothelial cell growth factor antagonists |
05/11/1994 | WO1994010197A1 A novel protein tyrosine kinase |
05/11/1994 | WO1994010172A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof |
05/11/1994 | WO1994010169A1 Method for preparing taxane derivatives |
05/11/1994 | WO1994010165A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
05/11/1994 | WO1994010142A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
05/11/1994 | WO1994010140A1 High purity beta-carotene |
05/11/1994 | WO1994010138A1 Inhibitors of farnesyl-protein transferase |
05/11/1994 | WO1994010137A1 Inhibitors of farnesyl-protein transferase |
05/11/1994 | WO1994009820A1 Prostate-specific membrane antigen |
05/11/1994 | WO1994009815A1 USES OF TGF-β RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT |
05/11/1994 | WO1994009785A2 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
05/11/1994 | WO1994009776A1 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-retroviral agents and anti-tumor agents |
05/11/1994 | WO1994009766A1 Inhibitors of farnesyl-protein transferase |
05/11/1994 | EP0596725A2 Drug resistance-conferring protein, antibodies reactive therewith and utilities thereof |
05/11/1994 | EP0596350A1 Cyclopeptides |
05/11/1994 | EP0596326A1 Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing the same, use thereof and precesses for their production |
05/11/1994 | EP0595935A1 Papilloma virus vaccine |
05/11/1994 | EP0595888A1 A process for the preparation of demethylepypodophyllotoxin. |
05/11/1994 | EP0595873A1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
05/11/1994 | EP0595838A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
05/11/1994 | EP0595826A1 2'-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents |
05/11/1994 | EP0595822A1 Thyroidal receptor for n-acetylglucosamine |
05/11/1994 | EP0595798A1 Bispecific heteroantibodies with dual effector functions |
05/11/1994 | EP0595796A1 Method of treatment of androgen-related diseases |
05/11/1994 | EP0344297B1 Treatment of cancer with somatostatin and analogs thereof |
05/11/1994 | CN1086512A Method for preparation of taxol |
05/11/1994 | CN1086421A Pharmaceutical composition inhibiting metastasis of cancer to liver and pharmaceutical composition treating liver cancer |
05/11/1994 | CA2148455A1 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-retroviral agents and anti-tumor agents |
05/11/1994 | CA2148258A1 Transcription factor dp-1 |
05/11/1994 | CA2148244A1 Angiogenesis inhibitory antibodies |
05/11/1994 | CA2147866A1 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
05/11/1994 | CA2147825A1 High purity beta-carotene |
05/11/1994 | CA2147509A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof |
05/11/1994 | CA2147286A1 Inhebitors of farnesyl-protein transferase |
05/11/1994 | CA2147241A1 Inhibitors of farnesyl-protein transferase |
05/11/1994 | CA2147240A1 Inhibitors of farnesyl-protein transferase |
05/11/1994 | CA2146767A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
05/10/1994 | US5310873 Cyclohexapeptide compound |
05/10/1994 | US5310763 Hydroxamino acid based collagenase inhibitors |
05/10/1994 | US5310554 Plant and solvent extraction |
05/10/1994 | CA1329446C Peptides with laminin activity |
05/10/1994 | CA1329392C Imidazole and triazole derivatives and antiviral and radiosensitizing agents comprising same |
05/06/1994 | CA2102256A1 Drug resistance-conferring protein, antibodies reactive therewith and utilities thereof |
05/04/1994 | EP0595557A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
05/04/1994 | EP0595467A2 Process for preparing antifolate 4-hydroxypyrrolo 2,3-d pyrimidine derivatives |
05/04/1994 | EP0595370A2 Process for the preparation of taxane derivatives and intermediates therefor |
05/04/1994 | EP0595151A2 Imidazopyridine derivates as antagonists of angiotensin II |
05/04/1994 | EP0595133A2 Prodrugs, their preparation and use as medicaments |
05/04/1994 | EP0594999A1 Phospholipid derivatives containing higher elements of the fifth main group |
05/04/1994 | EP0594739A1 Cancer treatment |
05/04/1994 | EP0594732A1 Humanized antibody against cd18 |
05/04/1994 | EP0594667A1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
05/04/1994 | EP0594624A1 Dynemicin analogs: syntheses, methods of preparation and use |
05/04/1994 | EP0594581A1 Production of glycosides, especially of steroidal glycosides |
05/04/1994 | EP0594577A1 Novel potent inducers of terminal differentiation and method of use thereof |
05/04/1994 | EP0428700B1 Irreversible bombesin antagonists |
05/03/1994 | US5308866 Treatment of melatonin related disorders, sleep disorders, psychological disorders |
05/03/1994 | US5308618 Dietary fiber extracted from wheat bran pharmaceutical and dietary compositions containing same |
05/03/1994 | CA1329195C Steroids useful as anti-cancer and anti-obesity agents |
05/03/1994 | CA1329156C Immunoglobulin conjugates |
05/03/1994 | CA1329126C Compounds having anti-progestational and anti-estrogenic activities for induction of labor and for termination of pregnancy, as well as for the treatment of gynecological disorders |
05/03/1994 | CA1329120C Pre-activated therapeutic agents derived from photoactive compounds |
04/28/1994 | WO1994009160A1 Method of inhibiting replication of hyperproliferative cells |
04/28/1994 | WO1994009138A1 Interleukin-6 receptor antagonists |
04/28/1994 | WO1994009120A1 Retroviral mediated transfer of the human multiple drug resistance gene |
04/28/1994 | WO1994009056A1 Chelating polymers |
04/28/1994 | WO1994009037A1 A NEW CLASS OF RPTPases: THEIR STRUCTURAL DOMAINS AND LIGANDS |
04/28/1994 | WO1994009010A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
04/28/1994 | WO1994008984A1 Novel taxane derivatives, their preparation and pharmaceutical compositions containing them |
04/28/1994 | WO1994008949A2 Metal-oxime chelates for use as radiopharmaceutical agents |
04/28/1994 | WO1994008625A1 Combination of antineoplastic agent and antisense oligonucleotides for treatment of cancer |
04/28/1994 | WO1994008621A1 Immunological purging of tumor cells from bone marrow using microspheres and monoclonal antibodies |
04/28/1994 | WO1994008601A1 Enhancement of b cell lymphoma tumor resistance using idiotype/cytokine conjugates |
04/28/1994 | WO1994008588A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
04/28/1994 | WO1994008584A1 Inhibitor for metastasis of malignant tumor |
04/28/1994 | WO1994008578A2 Tumoricidal activity of benzoquinonoid ansamycins against prostate cancer and primitive neural malignancies |
04/28/1994 | WO1994008574A1 Treatment of cachexia and inhibition of il-6 activity |
04/28/1994 | WO1994008564A1 Composition of antineoplastic agents incorporated in micelles |
04/28/1994 | WO1993024640A3 Methods and compositions for in vivo gene therapy |
04/28/1994 | DE4244715A1 Isolation of circulating cancer cells from bloodstream |
04/28/1994 | CA2147663A1 Combination of antineoplastic agent and antisense oligonucleotides for treatment of cancer |
04/28/1994 | CA2147466A1 Interleukin-6 receptor antagonists |
04/28/1994 | CA2147352A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives and use thereof |